Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02121314Phase 2Completed
A Phase 2 trial of isoniazid, rifampicin, pyrazinamide, ethambutol in Tuberculosis (TB), sponsored by University Medical Center Groningen. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02121314.